Consolidated Statement Of Income

Daito Pharmaceutical Co., Ltd. - Filing #7310181

Concept 2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
Consolidated statement of income
Statement of income
Net sales
46,895,000,000 JPY
46,592,000,000 JPY
45,101,000,000 JPY
44,695,000,000 JPY
Cost of sales
37,056,000,000 JPY
37,363,000,000 JPY
34,770,000,000 JPY
34,961,000,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
127,000,000 JPY
117,000,000 JPY
Depreciation
165,000,000 JPY
137,000,000 JPY
176,000,000 JPY
145,000,000 JPY
Operating expenses
Selling, general and administrative expenses
5,945,000,000 JPY
5,443,000,000 JPY
5,123,000,000 JPY
4,711,000,000 JPY
Operating expenses
Ordinary profit (loss)
3,923,000,000 JPY
3,872,000,000 JPY
5,169,000,000 JPY
5,082,000,000 JPY
General and administrative expenses
Salaries
Operating expenses
Research and development expenses
2,349,000,000 JPY
2,058,000,000 JPY
1,865,000,000 JPY
1,640,000,000 JPY
Gross profit (loss)
9,839,000,000 JPY
9,229,000,000 JPY
10,331,000,000 JPY
9,734,000,000 JPY
Operating profit (loss)
3,894,000,000 JPY
3,785,000,000 JPY
5,207,000,000 JPY
5,023,000,000 JPY
Net sales
Cost of sales
Selling, general and administrative expenses
Bonuses
210,000,000 JPY
231,000,000 JPY
Non-operating income
Interest income
0 JPY
13,000,000 JPY
0 JPY
7,000,000 JPY
Dividend income
65,000,000 JPY
111,000,000 JPY
57,000,000 JPY
118,000,000 JPY
Other
18,000,000 JPY
25,000,000 JPY
12,000,000 JPY
8,000,000 JPY
Non-operating income
126,000,000 JPY
165,000,000 JPY
86,000,000 JPY
149,000,000 JPY
Extraordinary income
461,000,000 JPY
461,000,000 JPY
12,000,000 JPY
12,000,000 JPY
Other
0 JPY
0 JPY
JPY
JPY
Extraordinary losses
166,000,000 JPY
165,000,000 JPY
105,000,000 JPY
229,000,000 JPY
Other
0 JPY
88,000,000 JPY
Non-operating expenses
97,000,000 JPY
79,000,000 JPY
124,000,000 JPY
89,000,000 JPY
Interest expenses
41,000,000 JPY
41,000,000 JPY
12,000,000 JPY
12,000,000 JPY
Non-operating expenses
Other
3,000,000 JPY
3,000,000 JPY
9,000,000 JPY
9,000,000 JPY
Profit (loss) before income taxes
4,218,000,000 JPY
4,168,000,000 JPY
5,076,000,000 JPY
4,866,000,000 JPY
Gross profit
Income taxes - current
902,000,000 JPY
749,000,000 JPY
1,595,000,000 JPY
1,408,000,000 JPY
Extraordinary income
Gain on sale of investment securities
326,000,000 JPY
326,000,000 JPY
JPY
JPY
Income taxes - deferred
138,000,000 JPY
169,000,000 JPY
-46,000,000 JPY
-34,000,000 JPY
Extraordinary losses
Loss on sale of investment securities
JPY
67,000,000 JPY
Loss on retirement of non-current assets
48,000,000 JPY
47,000,000 JPY
17,000,000 JPY
0 JPY
Income taxes
1,040,000,000 JPY
918,000,000 JPY
1,549,000,000 JPY
1,374,000,000 JPY
Profit (loss)
3,249,000,000 JPY
3,249,000,000 JPY
3,249,000,000 JPY
3,178,000,000 JPY
3,249,000,000 JPY
3,527,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY
Profit (loss) attributable to non-controlling interests
-116,000,000 JPY
-72,000,000 JPY
Profit (loss) attributable to owners of parent
3,295,000,000 JPY
3,295,000,000 JPY
3,295,000,000 JPY
3,600,000,000 JPY
3,600,000,000 JPY
3,600,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
173,000,000 JPY
281,000,000 JPY
Foreign currency translation adjustment
59,000,000 JPY
21,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-37,000,000 JPY
208,000,000 JPY
Other comprehensive income
194,000,000 JPY
511,000,000 JPY
Profit attributable to
Comprehensive income
3,373,000,000 JPY
4,038,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,476,000,000 JPY
4,107,000,000 JPY
Comprehensive income attributable to non-controlling interests
-102,000,000 JPY
-68,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.